hydroxyurea intolerance/resistance in polycythemia vera
Published 9 years ago • 1.7K plays • Length 20:15Download video MP4
Download video MP3
Similar videos
-
21:43
hydroxyurea intolerance/resistance in polycythemia vera
-
9:43
polycythemia vera: when to move from hydroxyurea to second-line therapy
-
9:19
debate: should jak inhibitors use be limited to hydroxyurea-resistant/intolerant pv patients? - no
-
4:25
srdan verstovsek, md, on predicting resistance to hydroxyurea therapy in polycythemia vera
-
15:55
debate: should jak inhibitors use be limited to hydroxyurea-resistant/intolerant pv patients? - yes
-
5:08
polycythemia vera - causes, symptoms, diagnosis, treatment, pathology
-
5:38
hyper segmented neutrophils due to hydroxycarbamide
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
27:23
interactive case: jak inhibitors for the successful management of polycythemia vera
-
19:36
evolution of the assessment of clinical benefit in polycythemia vera
-
17:54
current therapy options and clinical outcomes analysis in patients with pv
-
17:25
case study: inadequately controlled polycythemia vera (pv)
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
19:03
assessment of novel treatment options for patients with pv
-
0:54
polycythemia vera (pv): is resistance to hydroxyurea prognostic for adverse outcomes?
-
6:21
a case of hydroxyurea-intolerant polycythemia vera
-
20:53
debate: position of jak2 inhibitors as second line therapy in polycythemia vera
-
23:39
expert perspectives: jak inhibitors for polycythemia vera
-
1:57
dr. verstovsek on jak inhibition in polycythemia vera
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
17:02
indication for cytoreductive therapy in et and pv: do we have it right?
-
0:52
reveal study: long-term analysis of ruxolitinib in patients with polycythemia vera after hydroxyurea